Aβ Peptide Fibrillar Architectures Controlled by Conformational Constraints of the Monomer
Open Access
- 29 September 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (9) , e25157
Abstract
Anomalous self-assembly of the Aβ peptide into fibrillar amyloid deposits is strongly correlated with the development of Alzheimer's disease. Aβ fibril extension follows a template guided “dock and lock” mechanism where polymerisation is catalysed by the fibrillar ends. Using surface plasmon resonance (SPR) and quenched hydrogen-deuterium exchange NMR (H/D-exchange NMR), we have analysed the fibrillar structure and polymerisation properties of both the highly aggregation prone Aβ1–40 Glu22Gly (Aβ40Arc) and wild type Aβ1–40 (Aβ40WT). The solvent protection patterns from H/D exchange experiments suggest very similar structures of the fibrillar forms. However, through cross-seeding experiments monitored by SPR, we found that the monomeric form of Aβ40WT is significantly impaired to acquire the fibrillar architecture of Aβ40Arc. A detailed characterisation demonstrated that Aβ40WT has a restricted ability to dock and isomerise with high binding affinity onto Aβ40Arc fibrils. These results have general implications for the process of fibril assembly, where the rate of polymerisation, and consequently the architecture of the formed fibrils, is restricted by conformational constraints of the monomers. Interestingly, we also found that the kinetic rate of fibril formation rather than the thermodynamically lowest energy state determines the overall fibrillar structure.Keywords
This publication has 29 references indexed in Scilit:
- Amyloid-β Oligomer Specificity Mediated by the IgM Isotype – Implications for a Specific Protective Mechanism Exerted by Endogenous Auto-AntibodiesPLOS ONE, 2010
- Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer’s disease casesJournal of Neural Transmission, 2009
- Influence of Residue 22 on the Folding, Aggregation Profile, and Toxicity of the Alzheimer's Amyloid β PeptideBiophysical Journal, 2009
- Amyloid‐β protofibril levels correlate with spatial learning in Arctic Alzheimer’s disease transgenic miceThe FEBS Journal, 2009
- Amide solvent protection analysis demonstrates that amyloid-β(1–40) and amyloid-β(1–42) form different fibrillar structures under identical conditionsBiochemical Journal, 2007
- Alanine Scanning Mutagenesis of Aβ(1-40) Amyloid Fibril StabilityJournal of Molecular Biology, 2006
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- Small non-fibrillar assemblies of amyloid β-protein bearing the Arctic mutation induce rapid neuritic degenerationNeurobiology of Disease, 2005
- Mapping Aβ Amyloid Fibril Secondary Structure Using Scanning Proline MutagenesisJournal of Molecular Biology, 2004
- The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formationNature Neuroscience, 2001